Advanced Search

 

Study ID Status Title Patient Level Data
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116689 Completed An integrated review to evaluate dose response of umeclidinium (GSK573719) administered once or twice daily in Subjects with COPD
116844 Completed Meta-Analysis Results Report for DB2116844: Meta-analysis of DB2113360 and DB2113374: an Integrated Review of Transition Dyspnoea Index data for Umeclidinium/Vilanterol, Umeclidinium, Vilanterol and Tiotropium over 24 Weeks in Subjects with COPD
117170 Active, Not Recruiting Analysis Plan for the Integrated Analysis of Cardiovascular Risk Among Type II Diabetes Subjects Exposed to GSK716155 in the Phase III Program
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200239 Completed Longitudinal Analysis of Efficacy and Safety of Alitretinoin in Patients with Severe Chronic Hand Eczema Refractory to Corticosteroids
200277 Active, Not Recruiting Meta-Analysis Plan for liver analyses with GW786034 (pazopanib) treatment in advanced/metastatic renal cell carcinoma and soft tissue sarcoma to support a regulatory post marketing requirement
200382 Completed Cost-effectiveness of combined use of ropinirole controlled-release and L-dopa compared with L-dopa monotherapy in patients with Parkinson's disease
200791 Completed Clinical Pharmacology Reporting and Analysis Plan for a Combined Analyses to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration)
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201223 Active, Not Recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201832 Completed 201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects with Asthma and Exercise-Induced Bronchoconstriction
202161 Completed A clinical study investigating the efficacy of a dentifrice in providing immediate and short term relief from dentinal hypersensitivity
202172 Terminated A Study to Assess Efficacy over Placebo and Speed of Onset of Pain Relief of new Paracetamol and caffeine tablets as Compared to Ibuprofen in Episodic Tension Type Headache
202177 Completed A Clinical Study to Assess the Efficacy of Pain Relief of Topical Indomethacin Patch over Placebo in Ankle Sprain Patients
202178 Completed A Magnetic Resonance Imaging Study of Nasal Strips in Subjects with Nasal Congestion
202179 Completed A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle Sprain
202182 Completed A study to evaluate the effect of a 67% Sodium Bicarbonate containing toothpaste on Chlorhexidine Digluconate tooth staining
202187 Completed A Cumulative Skin Irritation Study Investigating the Skin Irritancy Potential of MFC51123 Diclofenac-Menthol Gel
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model
206823 Completed PGx7660: Exploratory Pharmacogenetic Investigation of Efficacy Response to Relvar/Breo in Phase III COPD studies 112206, 112207, 113108, and 200820
207521 Completed PGx7673: Confirmatory Genetics Reporting and Analysis Plan: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL113750 (eTrack Study ID 207521)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.